Form 4 for DMRA Damora Therapeutics, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-004573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | DMRA | Schambye Hans T. | CEO, Dir | M - OptEx | — | +1,360 | 5,382 | +34% | — |
| D | 2026-01-06 | 2026-01-02 | DMRA | Schambye Hans T. | CEO, Dir | S - Sale+OE | $21.38 | -700 | 4,682 | -13% | -$15.0K |
| D | 2026-01-06 | 2026-01-02 | DMRA | Schambye Hans T. | CEO, Dir | M - OptEx | $0.00 | -1,360 | 2,640 | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | M | A | 1,360 | — | 5,382 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. |
| 2 | Common | Common Stock | 2026-01-02 | S | D | 700 | $21.38 | 4,682 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-02 | M | D | 1,360 | $0.00 | 2,640 | D | — · — to — | 1,360 Common Stock | (F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. (F3) This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date. |